Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Studying of clinical and laboratory features of chronic eosinophilic leukemias /hypereosinophilic syndrome].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 1 Jan 2008

Zhang Yue, Yu Ming-Hua, Xu Shi-Cai, Yang Lin, Yu Yang, Hao Yu-Shu, Xiao Zhi-Jian

Abstract excerpt

OBJECTIVE: To investigate the clinical and laboratory features of chronic eosinophilic leukemias (CEL) and hypereosinophilic syndrome (HES). METHODS: The clinical manifestations, laboratory parameters were retrospectively analyzed in 20 patients with HES/CEL. Detection of the FIP1L1-PDGFRA fusion gene was performed by nested RT-PCR. JAK2 V617F mutation screening was processed through allele-specific PCR combined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CEL gene
Share to Gene Rearrangement

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hypereosinophilic Syndrome

Share to Janus Kinase 2

Share to mRNA Cleavage and Polyadenylation Factors

Share to Mutation

Share to Receptor, Platelet-Derived Growth Factor alpha

Share to Young Adult

Source

Identifiers

PMID: 18512307

Genes

CEL
PDGFRA
JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Studying of clinical and laboratory features of chronic eosinophilic leukemias /hypereosinophilic syndrome].PMID 18512307Read ↗

The hypereosinophilic syndromes: current concepts and treatments.Semantic proximity Read ↗

Chronic Eosinophilic Leukemias and the Myeloproliferative Variant of the Hypereosinophilic SyndromeSemantic proximity Read ↗

Molecular Classification and Pathogenesis of Eosinophilic Disorders: 2005 UpdateSemantic proximity Read ↗

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.Semantic proximity Read ↗

The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and managementSemantic proximity Read ↗

World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.Semantic proximity Read ↗

Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosisSemantic proximity Read ↗

Hypereosinophilic syndrome.Semantic proximity Read ↗

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.Semantic proximity Read ↗

Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.Semantic proximity Read ↗

[Chronic neutrophilic leukemia/chronic eosinophilic leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.